EDITAS MEDICINE, INC. (EDIT) Debt Components
- 2026-06-30: Long-term Debt, Current MaturitiesUSD $7.50M; Long-term Debt, Excluding Current MaturitiesUSD $48.24M; Long-term DebtUSD (m); Notes PayableUSD (m).
- 2026-03-31: Long-term Debt, Current MaturitiesUSD $7.50M; Long-term Debt, Excluding Current MaturitiesUSD $47.18M; Long-term DebtUSD (m); Notes PayableUSD (m).
- 2025-12-31: Long-term Debt, Current MaturitiesUSD $5.00M; Long-term Debt, Excluding Current MaturitiesUSD $53.60M; Long-term DebtUSD (m); Notes PayableUSD (m).
- 2025-09-30: Long-term Debt, Current MaturitiesUSD $5.00M; Long-term Debt, Excluding Current MaturitiesUSD $54.07M; Long-term DebtUSD (m); Notes PayableUSD (m).
EDITAS MEDICINE, INC. Debt Components
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Long-term Debt, Current Maturities USD | Long-term Debt, Excluding Current Maturities USD | Long-term Debt USD | Notes Payable USD |
|---|---|---|---|---|
| 2026-06-30 | $7.50M | $48.24M | (m) | (m) |
| 2026-03-31 | $7.50M | $47.18M | (m) | (m) |
| 2025-12-31 | $5.00M | $53.60M | (m) | (m) |
| 2025-09-30 | $5.00M | $54.07M | (m) | (m) |
| 2025-06-30 | $5.00M | $51.67M | (m) | (m) |
| 2025-03-31 | $5.00M | $49.58M | (m) | (m) |
| 2024-12-31 | $5.00M | $52.43M | (m) | (m) |
| 2024-12-31 | (m) | (m) | $57.43M | (m) |
| 2023-12-31 | $0.00 | $0.00 | (m) | (m) |
| 2017-12-31 | (m) | (m) | (m) | $7.50M |
| 2017-06-30 | (m) | (m) | (m) | $15.00M |
| 2017-03-31 | (m) | (m) | (m) | $15.00M |
| 2016-12-31 | (m) | (m) | (m) | $10.00M |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| Tectonic Therapeutic, Inc. (TECX) | United States | $0.469B | -7.68 |
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |